Regeneron director George L. Sing sells 2,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Regeneron Pharmaceuticals, Inc. director George L. Sing reported sales of 2,000 common shares on November 16 and 17, 2026. On November 16, he sold 1,000 shares at a volume-weighted average price of $960.26 per share. On November 17, he sold 176 shares at $956.96 per share, 359 shares at a volume-weighted average price of $957.49 per share, and 465 shares at a volume-weighted average price of $958.11 per share. No Rule 10b5-1 plan is reported.
Indirect holding entries dated November 16 list 750 shares by his spouse, 400 shares by spouse/custodial son, and 1,000 shares by a trust for his son.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 176 | $956.96 | $168K |
| Sale | Common Stock F2 | 359 | $957.49 | $344K |
| Sale | Common Stock F3 | 465 | $958.11 | $446K |
| Sale | Common Stock F1 | 1,000 | $960.26 | $960K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 16, 2026 at prices ranging from $960.00 to $960.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F2. Represents volume-weighted average price of sales of 359 shares of Company stock on November 17, 2026 at prices ranging from $957.24 to $957.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
- F3. Represents volume-weighted average price of sales of 465 shares of Company stock on November 17, 2026 at prices ranging from $958.01 to $958.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2026 at each separate price.
Key Figures
Key Terms
volume-weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.